March was an exceptionally productive month for MISSD!
Marcey Berman (r) and Kristina Kaiser (l) shared MISSD’s educational resources at the annual conference of the National Learning Disabilities Association of America.
MISSD is pleased that our educational resources will reach professionals attending this week’s Learning Disabilities of America annual conference. Children prescribed meds with known risks of suicidality and adverse psychiatric effects deserve informed care prior to prescribing.
Fact: A 2020 study found that 6.5% of U.S. children (ages 3–17) take psychiatric meds, and many more are given meds that can cause suidicality. Awareness is critical to reduce harm and save lives.
Twelve years ago today, Natalie died a Zoloft-induced death. Like many, if not most, akathisia deaths, the symptoms were missed, misdiagnosed & mistreated. Take our free, accredited course to learn about akathisia symptoms, causes, risks, and management at MISSD.LearnUpon.com. When Natalie was suffering from akathisia, her prescriber increased Zoloft, the drug causing akathisia. This mistake is unfortunately not rare and can be deadly.
MISSD has long recommended a medication buddy system so that anyone starting, stopping, or changing dose or type of medications associated with akathisia can be closely monitored for any unusual changes in thoughts and/or behavior. The parents of Thomas Kingston, who died of medication-induced suicide, are recommending a similar medication buddy system. We hope this precaution is promoted and becomes standard procedure. Read the full article at https://www.bbc.com/news/articles/c5y76kd8x6no.
The BMJ reports that a coroner is questioning whether there is enough information provided about the suicide risks all SSRIs pose.
Katy Skerrett, senior coroner for Gloucestershire, has sent a regulation 28 report, intended to prevent future deaths. MISSD believes medications that can cause akathisia-induced death, to include SSRIs, should have a bold and clear warning and that doctors and patients should be fully informed prior to prescribing.
The prescription drugs taken as directed by Thomas Kingston before he died have ben flagged more than 40 times by coroners, it has been found.
The 45-year-old husband of Lady Gabriella Windsor ended his life in February last year at his parents’ home in the Cotswolds. The financier had been prescribed two selective serotonin reuptake inhibitors (SSRIs) – and zopiclone, a sleeping tablet, before his death.
“Following an inquest into his death, senior coroner for Gloucestershire Katy Skerrett concluded that the financier was “suffering adverse effects” of medication he had recently been prescribed.
In a prevention of future deaths report (PFD), she questioned whether there is adequate communication of the risks of suicide associated with such medication. Ms Skerrett is the latest in a string of coroners to have referenced either citalopram or sertraline in reports. Analysis by The Times found that at least 40 PFD reports mentioned the use of the SSRIs by the deceased person.”
MISSD is dedicated to promoting truth in disclosure, honesty in reporting and legitimate drug trials. This recent article explains well how ghost written medical journal articles, fraudulent clinical drug trials, and weak drug regulations increase akathisia and related iatrogenic harm. Read the full article at https://rxisk.org/who-will-make-medicine-great-again/.
We’re so please to share this special collaboration with an Ohio family who share their akathisia experiences so that others can be safer and better informed. While the Cleveland Clinic does have an akathisia webpage, as Shelly and Wendy Dolin, MISSD’s founder, point out, it isn’t enough to ensure proper diagnosis and effective care.
Author Archives: admin
